This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
SUS provides full, free and universal access to healthcare for the country's entire population (215 million), which spends around 10% of its gross domestic product (GDP) on healthcare. Only a limited number of international pharmacompanies, however, operate manufacturing sites in the country.
Once vaccination levels reach critical mass, people will once again return to their physician’s offices. Let’s be clear about pharmaproduct websites. In short, online health seekers aren’t finding compelling reasons to ask for your product on your website. Having just a website is not enough.
Consider Pfizer’s Science Will Win campaign, which highlighted the companys dedication to vaccine development. A marketing network is a system of connected individuals and tools that help promote and distribute pharmaproducts effectively. How can pharmacompanies build HCP networks?
Although medicines tend to be excluded from trade sanctions as they cause loss of life, Russian pharmacompanies may struggle to secure funding in the face of economic sanctions and there may also be a disruption to non-essential medicines. million vaccine doses upon EMA authorisation.
In light of the Covid-19 pandemic, the war in Ukraine, and the Russian gas supply issue, several countries have called for onshoring, also referred to as reshoring; the bringing back of pharmaproduction to locations within national borders to mitigate costs, supply issues, and concerns regarding bilateral relations.
The value of real-time data Amid unprecedented instability in lockdown-stricken supply chains, digital transformation company Controlant helped to safely deliver more than 5 billion COVID-19 vaccines. So we’ve got a standard process that we’re executing quite a few times throughout the life cycle of the product itself.”
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content